Viewing Study NCT00520533


Ignite Creation Date: 2025-12-25 @ 2:43 AM
Ignite Modification Date: 2026-02-04 @ 2:28 PM
Study NCT ID: NCT00520533
Status: TERMINATED
Last Update Posted: 2022-10-12
First Post: 2007-08-22
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Study of Safety and Functional Imaging of cG250 and Sunitinib in Patients With Advanced Renal Cell Carcinoma
Sponsor: Ludwig Institute for Cancer Research
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Renal Cell Carcinoma (RCC) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Clinical trials View
None cG250 mAb View
None monoclonal antibody (mAb) G250 View
None sunitinib View
None angiogenesis inhibitors View
None Positron-Emission Tomography View
None Pharmacokinetics View
None Pharmacodynamics View